Large Genomic Rearrangements in the Hepatocyte Nuclear Factor-1β (TCF2) Gene Are the Most Frequent Cause of Maturity-Onset Diabetes of the Young Type 5

  1. Christine Bellanné-Chantelot1,
  2. Séverine Clauin1,
  3. Dominique Chauveau2,
  4. Philippe Collin3,
  5. Michèle Daumont4,
  6. Claire Douillard5,
  7. Danièle Dubois-Laforgue6,
  8. Laurent Dusselier7,
  9. Jean-François Gautier8,
  10. Michel Jadoul9,
  11. Marie Laloi-Michelin10,
  12. Laetitia Jacquesson11,
  13. Etienne Larger12,
  14. Jacques Louis7,
  15. Marc Nicolino13,
  16. Jean-François Subra14,
  17. Jean-Marie Wilhem15,
  18. Jacques Young16,
  19. Gilberto Velho17 and
  20. José Timsit6
  1. 1Department of Cytogenetics and Molecular Biology, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France
  2. 2Department of Nephrology, Hôpital de Rangueil, Toulouse, France
  3. 3Department of Internal Medicine, Centre Hospitalier de Niort, Niort, France
  4. 4Department of Endocrinology, Centre Hospitalier de Vienne, Vienne, France
  5. 5Department of Endocrinology, Centre Hospitalier de Béthune, Béthune, France
  6. 6Department of Immunology and Diabetology, Paris Descartes University, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France
  7. 7Department of Endocrinology, Hôpital Sainte-Blandine, Metz, France
  8. 8Department of Endocrinology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
  9. 9Cliniques Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium
  10. 10Department of Internal Medicine, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France
  11. 11Department of Endocrinology, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France
  12. 12Department of Endocrinology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France
  13. 13Department of Endocrinology, Hôpital Debrousse, Lyon, France
  14. 14Department of Nephrology, Centre Hospitalier Universitaire d’Angers, Angers, France
  15. 15Department of Internal Medicine, Centre Hospitalier Saint-Morand, Altkirch, France
  16. 16Department of Endocrinology, Hôpital de Kremlin-Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France
  17. 17Inserm U695, Faculté de Médecine Xavier Bichat, Paris, France
  1. Address correspondence and reprint requests to Christine Bellanne-Chantelot, Hopital Saint Antoine, Service de Cytogenetique, 184 Rue du Faubourg Saint-Antoine, 75012 Paris, France. E-mail: christine.bellanne{at}sat.ap-hop-paris.fr

Abstract

Maturity-onset diabetes of the young (MODY) 5 is caused by mutations in the TCF2 gene encoding the transcription factor hepatocyte nuclear factor-1β. However, in 60% of the patients with a phenotype suggesting MODY5, no point mutation is detected in TCF2. We have hypothesized that large genomic rearrangements of TCF2 that are missed by conventional screening methods may account for this observation. In 40 unrelated patients presenting with MODY5 phenotype, TCF2 was screened for mutations by sequencing. Patients without mutations were then screened for TCF2 rearrangements by the quantitative multiplex PCR of short fluorescent fragments (QMPSF). Among the 40 patients, the overall detection rate was 70%: 18 had point mutations, 9 had whole-gene deletions, and 1 had a deletion of a single exon. Similar phenotypes were observed in patients with mutations and in subjects with large deletions. These results suggest that MODY5 is more prevalent than previously reported, with one-third of the cases resulting from large deletions of TCF2. Because QMPSF is more rapid and cost effective than sequencing, we propose that patients whose phenotype is consistent with MODY5 should be screened first with the QMPSF assay. In addition, other MODY genes should be screened for large genomic rearrangements.

Footnotes

« Previous | Next Article »Table of Contents